PD-L1 Biomarker- OptraSCAN Inc
OptraSCAN Inc offers PD-L1 biomarker & immune-oncology biomarker analysis for immune-oncology – programmed death-ligand 1 (PD-l1) expression.
Programmed Cell Death Ligand-1 expression of PD-L1 is a very important cancer
biomarker and it has become a critical part of patient management for
immunotherapy. The targeted blockade of PD-L1 helps to restore the antitumor
response.
Because of the development
of the combined positive score (CPS) for the evaluation of PD-L1 in solid
tumors. It has been indicated that PD-L1 expression on both tumor and
tumor-associated immune cells is associated with clinical outcomes.
Optrascan’s
Solution For Immuno - Oncology:
- - It’s
an automated image analysis (for research use) which supports the interpretation of
PD-L1I HC expression on both tumor and immune cells in solid tumors.
- -= They
determines PD-L1 expression on tumor and immune cells showing partial or
complete membrane staining on a tumor cell along with membrane and/or
cytoplasmic staining on immune cells in a single read.
- - It is very reliable and can be used to assess PD- L1 expression in a more objective manner.
Tel:
+1-408-524-5300
Contact
us at- info@optrascan.com
Comments
Post a Comment